CC
VYGR icon

Casdin Capital’s Voyager Therapeutics VYGR Stock Holding History

Casdin Capital’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-750,000
Closed -$9.46M – 46
2020
Q2 		$9.46M Sell
750,000
-345,075
-32% -$4.01M 0.56% 36
2020
Q1 		$10M Hold
1,095,075
– – 1.06% 27
2019
Q4 		$15.3M Sell
1,095,075
-33,000
-3% -$480K 1.4% 24
2019
Q3 		$19.4M Hold
1,128,075
– – 2.01% 17
2019
Q2 		$30.7M Hold
1,128,075
– – 2.87% 14
2019
Q1 		$21.6M Hold
1,128,075
– – 2.37% 16
2018
Q4 		$10.6M Sell
1,128,075
-6,925
-0.6% -$88.9K 1.81% 23
2018
Q3 		$21.5M Hold
1,135,000
– – 2.61% 18
2018
Q2 		$22.2M Hold
1,135,000
– – 3.1% 13
2018
Q1 		$21.3M Hold
1,135,000
– – 3.75% 14
2017
Q4 		$18.8M Buy
1,135,000
+320,000
+39% +$5.49M 4.59% 10
2017
Q3 		$16.8M Buy
815,000
+75,000
+10% +$846K 4.74% 11
2017
Q2 		$6.63M Buy
740,000
+240,000
+48% +$2.42M 2.45% 18
2017
Q1 		$6.62M Buy
500,000
+115,000
+30% +$1.4M 3.91% 9
2016
Q4 		$4.91M Buy
385,000
+108,500
+39% +$1.39M 4.05% 10
2016
Q3 		$3.32M Sell
276,500
-46,000
-14% -$623K 2.69% 13
2016
Q2 		$3.54M Sell
322,500
-16,862
-5% -$206K 3.53% 13
2016
Q1 		$2.96M Buy
339,362
+102,500
+43% +$1.16M 3.4% 13
2015
Q4 		$5.19M Buy
+236,862
New +$5.46M 4.58% 13

Other funds holding VYGR

TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Casdin Capital's VYGR Position: Q3 2020 in Review

Casdin Capital sold out of Voyager Therapeutics (VYGR) in Q3 2020, closing a stake of 750,000 shares — an estimated $9.46M sold.

Casdin Capital first reported a position in VYGR in Q4 2015 and held it in 19 quarters. The position peaked at $30.7M in Q2 2019. 110 funds tracked by Wall St. Rank hold VYGR as of Q3 2020.

  • Casdin Capital reported no remaining Voyager Therapeutics position as of Q3 2020 after selling out during the quarter.
  • Casdin Capital sold 750,000 Voyager Therapeutics shares in Q3 2020, an estimated $9.46M.
  • Casdin Capital first reported a position in Voyager Therapeutics in Q4 2015 and held it in 19 quarters.
  • Casdin Capital's Voyager Therapeutics position peaked at $30.7M in Q2 2019.
  • 110 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q3 2020.

Based on Casdin Capital's 13F filing for Q3 2020, filed 16 Nov 2020.